Abstract
Protein tyrosine phosphorylation regulates the production of capsular polysaccharide, an essential virulence factor of the deadly pathogen Vibrio vulnificus. The process requires the protein tyrosine kinase Wzc and its cognate phosphatase Wzb, both of which are largely uncharacterized. Herein, we report the structures of Wzb of V. vulnificus (VvWzb) in free and ligand-bound forms. VvWzb belongs to the low-molecular-weight protein tyrosine phosphatase (LMWPTP) family. Interestingly, it contains an extra four-residue insertion in the W-loop, distinct from all known LMWPTPs. The W-loop of VvWzb protrudes from the protein body in the free structure, but undergoes significant conformational changes to fold toward the active site upon ligand binding. Deleting the four-residue insertion from the W-loop severely impaired the enzymatic activity of VvWzb, indicating its importance for optimal catalysis. However, mutating individual residues or even substituting the whole insertion with four alanine residues only modestly decreased the enzymatic activity, suggesting that the contribution of the insertion to catalysis is not determined by the sequence specificity. Furthermore, inserting the four residues into Escherichia coli Wzb at the corresponding position enhanced its activity as well, indicating that the four-residue insertion in the W-loop can act as a general activity enhancing element for other LMWPTPs. The novel W-loop type and phylogenetic analysis suggested that VvWzb and its homologs should be classified into a new group of LMWPTPs. Our study sheds new insight into the catalytic mechanism and structural diversity of the LMWPTP family and promotes the understanding of the protein tyrosine phosphorylation system in prokaryotes.
Keywords: Vibrio vulnificus, low-molecular-weight protein tyrosine phosphatase (LMWPTP), tyrosine phosphorylation, Wzb, capsular polysaccharide, virulence factor, indel, protein structure, enzyme mechanism, infectious disease, phosphotyrosine
Abbreviations: CPS, capsular polysaccharide; IPTG, isopropyl-β-D-thiogalactopyranoside; LMWPTP, low-molecular-weight protein tyrosine phosphatase; PEG, polyethylene glycol; pNPP, para-nitrophenyl phosphate; rmsd, root-mean-square deviation; TEV, tobacco etch virus
Phosphorylation on protein tyrosine is a posttranslational modification with essential roles in life. In eukaryotes, it has been extensively studied as an essential regulatory mechanism in various cellular processes (1). In contrast, protein tyrosine phosphorylation in prokaryotes was recognized much later than in eukaryotes (2). It regulates a couple of processes in prokaryotes, including polysaccharide synthesis, biofilm formation, and cell growth (3, 4, 5, 6). With technique developments in recent years, more proteins with various functions have been identified to be tyrosine-phosphorylated in bacteria and archaea (7, 8). Now it has been recognized that protein tyrosine phosphorylation is a key regulation paradigm in the physiology and pathology of prokaryotes (9, 10, 11). Yet, our knowledge on prokaryotic protein tyrosine phosphorylation system is very limited.
Vibrio vulnificus is the most deadly foodborne pathogen, causing gastroenteritis, wound infection, and severe septicaemia with an over 50% mortality rate (12). It is also an important pathogen for marine animals, causing huge economic loss in aquaculture industry (13). In V. vulnificus, protein tyrosine phosphorylation plays a key role in the production of capsular polysaccharide (CPS), one essential virulence factor for the pathogen to escape host immune response (14). The CPS synthesis gene locus of V. vulnificus is similar to that of the group 1 or 4 capsules of Escherichia coli (15). In E. coli, the relationship between tyrosine phosphorylation and CPS production has been basically elucidated. Three conserved proteins Wza-Wzb-Wzc are responsible for polymerization control and translocation of CPS (16). Specifically, Wza is the translocon of CPS, while Wzc and Wzb form a kinase/phosphatase pair required for high-level polymerization of polysaccharide (Fig. 1). Wzc belongs to the family of bacterial tyrosine kinases (BY kinases), a distinct class of kinases that have no homologs in eukaryotes. Wzc acts as an autokinase to phosphorylate its own tyrosine-rich C-terminal tail and other sites, resulting in a high phosphorylated Wzc, while the cognate phosphatase Wzb dephosphorylates Wzc to a low phosphorylation state. The cycling of Wzc between high and low phosphorylation states regulates the production of CPS, with the mechanism remaining elusive (16, 17). The exact situation in V. vulnificus is unknown yet but supposed to work in an analogous manner. Nevertheless, there are experiment evidences to directly connect tyrosine phosphorylation to CPS production in V. vulnificus. In studies of colony morphologies, Wzb of V. vulnificus (VvWzb) was found to be a switch of morphological transition among opaque, translucent, and intermediate phases through controlling CPS production (18). Deletion of VvWzb led to CPS production defect and attenuated virulence of the bacterium. It was also observed that the expression levels of Wzb and Wzc were correlated to CPS production (19). So far, V. vulnificus Wzb and Wzc have not been biochemically characterized yet, which hinders further understanding of the phosphorylation events in this deadly pathogen. In this study, we would focus on the characterization of VvWzb.
Figure 1.
Schematic presentation of the interactions of Wza, Wzb, and Wzc. Wza forms an octamer for CPS export and Wzc forms an oligomer to interact with Wza. The production of CPS requires Wzc cycling between the high and low phosphorylation states, which is a combined result of the autokinase activity of Wzc and the phosphotase activity of Wzb. CM, cytoplasmic membrane; OM, outer membrane.
VvWzb belongs to the family of low-molecular-weight protein tyrosine phosphatase (LMWPTP). LMWPTPs are small (ca. 18 kDa), evolutionally conserved and important enzymes involved in various cellular processes of all kingdoms of life (20). They have been extensively studied over decades for the functional importance and druggability potential. So far, a number of structures of LMWPTPs from both eukaryotes and prokaryotes have been determined (21, 22, 23, 24, 25, 26, 27, 28, 29, 30). They share a common α/β fold; the active site crevice is composed of three characteristic loops, named the P-, D-, and W-loops, respectively. The P-loop bears the characteristic active-site motif “CXGNXCRS” (X can be any amino acid) with the first cysteine as the catalytic nucleophile; this loop is at the bottom of the active site crevice, extensively interacting with the phosphate group of substrate, thus named P-loop. The D-loop forms a wall of the active site crevice. It contains a catalytically important aspartate residue, which acts as a general acid/base, and also contains a tyrosine residue to stabilize the phenyl ring of the substrate. The third is a variable loop, forming another wall of the active site crevice and being responsible for substrate recognition. In the structures of eukaryotic and some prokaryotic LMWPTPs, an aromatic residue such as tryptophan is located at the variable loop to interact with the phenyl ring of the tyrosine phosphate. Thus, this loop is conveniently called W-loop. Nevertheless, the study on the structure of E. coli Wzb (EcWzb) uncovered another type of W-loop in prokaryotic LMWPTPs, which lacks this important aromatic residue and thus recognizes substrate in a different way (23). Noticeably, this study also showed that the W-loop type is a good marker to classify LMWPTPs. Indeed, the phylogenetic analysis confirmed that LMWPTPs can be divided into two categories, in agreement with the W-loop forms they have (23, 31). Hereafter, we would name the two categories of LMWPTPs as group I and II, prototyped by mammalian LMWPTPs and EcWzb, respectively. Interestingly, VvWzb is different from any structurally known LMWPTP by harboring a unique short sequence insertion in the W-loop, excluding VvWzb from either group (Fig. 2A). It is unclear if this could challenge the current classification paradigm of LMWPTP family. It also remains to know if the unique insertion would endow VvWzb with some new structural and enzymatic features.
Figure 2.
Sequence alignment and the overall structures.A, sequence alignment of LMWPTPs. The conserved residues are highlighted in red. The secondary structures as well as the P-, D-, and W-loops are indicated. B−D, structures of free VvWzb, VvWzb-benzylphosphonate complex, and VvWzbC9A-phosphate complex, respectively. Secondary structures, the N- and C-termini are annotated. The P-, D-, and W-loops are colored in yellow, blue, and magenta, respectively. The ligands benzylphosphonate and phosphate are shown as sticks.
Herein, we report crystal structures of free VvWzb, VvWzb complexed with benzylphosphonate, and VvWzbC9A complexed with phosphate. The structural and enzymatic analyses of VvWzb shed new insight into the classification and catalytic mechanism of the LMWPTP family. Our study also provides critical structural information for antivirulence drug design against V. vulnificus.
Results
Overall structures of VvWzb in free and ligand-bound forms
VvWzb crystallized in the space group P212121, with two protein molecules in one asymmetric unit. The two molecules formed a dimer in the crystal, with an interface area of about 900 Å2. However, this seems to be a crystallographic dimer, since VvWzb existed as a monomer in solution, indicated by gel filtration (Fig. S1). The structural model was built in good quality (Table 1). VvWzb adopts a typical LMWPTP α/β fold (Fig. 2B). In the middle is a twisted parallel β-sheet formed by four β-strands in the sequence of β4-β3-β1-β2; flanking the central β-sheet are five α-helices, with α4, α3 at one side and α1, α2, α5 at the other. The P-loop (between β1 and α1), D-loop (between β4 and α5), and W-loop (between β2 and α2) cluster together to form the active site crevice (Fig. 2B). Remarkably, the W-loop of VvWzb is longer than any known LMWPTP structure, due to a “40EKSR43” insertion (Fig. 2A). The W-loop adopts an extended conformation and protrudes from the protein body. The region harboring the unique insertion forms a small β-hairpin including two short β-strands (β1’ and β2’).
Table 1.
Crystallographic statistics
| Parameter | VvWzb | VvWzb-benzylphosphonate | VvWzbC9A-phosphate |
|---|---|---|---|
| Data collection statistics | |||
| X-ray source | BL19U1 | BL19U1 | BL18U1 |
| Wavelength (Å) | 0.9788 | 0.9788 | 0.9792 |
| Space group | P21 21 21 | P1 | P21 21 21 |
| Unit-cell dimensions (Å or °) | a = 47.32, b = 48.74, c = 117.32 | a = 44.11, b = 51.01, c = 68.59 | a = 60.97, b = 68.30, c = 132.96 |
| α = 90.00, β = 90.00, γ = 90.00 | α = 101.85, β = 95.56, γ = 103.79 | α = 90.00, β = 90.00, γ = 90.00 | |
| Resolution (Å) | 58.66−1.711 (1.740−1.711) | 48.14−2.785 (2.833−2.785) | 66.48−1.211 (1.232−1.211) |
| Unique reflections | 29,957 (1506) | 13,744 (689) | 161,631 (7689) |
| Completeness (%) | 99.5 (99.7) | 97.9 (97.9) | 95.7 (92.6) |
| Mean I/sigma(I) | 19.2 (2.3) | 16.4 (2.3) | 17.9 (2.2) |
| Multiplicity | 12.6 (12.9) | 3.6 (3.6) | 13.6 (13.9) |
| Rmerge (%) | 8.5 (118.8) | 4.7 (56.8) | 7.8 (107.7) |
| Rmeasure (%) | 8.8 (123.8) | 5.5 (66.6) | 8.1 (111.8) |
| Rpim (%) | 2.5 (34.3) | 2.9 (34.5) | 2.2 (29.7) |
| CC1/2 (%) | 99.9 (78.8) | 99.9 (81.1) | 99.9 (93.3) |
| Refinement statistics | |||
| Resolution range (Å) | 58.66−1.71 | 48.14−2.79 | 29.72−1.211 |
| Rwork/Rfree (%)a | 19.9/22.3 | 18.6/22.6 | 14.3/16.9 |
| Modeled residues | A: −1 to 146 B: −1 to 146 |
A: 1−146 B: 0−146 C: 1−146 D: 1−146 |
A: 1−146 B: 1−146 C: −2 to 146 D: −2 to 146 |
| Ligands | 2 Cl− | 4 benzylphosphonate | 4 phosphate ions, 1 glycerol |
| Water molecules | 270 | None | 679 |
| rmsd bond lengths (Å) | 0.010 | 0.010 | 0.002 |
| rmsd bond angles (°) | 1.02 | 1.12 | 0.59 |
| Ramachandran outliers | 0 | 0 | 0 |
| PDB code | 7DHD | 7DHE | 7DHF |
Values in parentheses represent the highest resolution shell.
∼5% of the reflections were selected randomly for calculating Rfree.
In the presence of benzylphosphonate, a compound that mimics the phenylphosphate moiety of the substrate phosphotyrosine, VvWzb and VvWzbC9A crystallized in space groups P1 and P212121, respectively. Both crystals contained four protein molecules in one asymmetric unit. The dimeric form observed in the free VvWzb crystal did not show up again, and instead two adjacent molecules were covalently crosslinked via a disulphide bond formed by the Cys61 residues of both molecules. We were able to model one benzylphosphonate molecule (with occupancy of 1 and B-factor of 82.8, 142.8, 109.6, or 89.9 Å2) for each of the four protein chains in the wild-type (WT) structure (Figs. 2C and 3A). However, only phosphate ions were identified in VvWzbC9A structure, judged by the unambiguous electron density (Figs. 2D and 3B). The source of the phosphate ion was not defined, presumably from benzylphosphonate degradation or contamination. The overall structures of VvWzb-benzylphosphonate and VvWzbC9A-phosphate are similar to that of free VvWzb, except that the W-loop underwent significant conformational changes to fold toward the active site in both structures (Fig. 2, C and D).
Figure 3.
Ligands in the complex structures.A, benzylphosphonate in VvWzb-benzylphosphonate structure. B, phosphate in VvWzbC9A-phosphate structure. The representative refined omit Fo-Fc maps contoured at 2.5 σ levels were shown as green meshes. The chemical structures of the ligands are displayed as insets. C, ligand-binding differences in VvWzb-benzylphosphonate and VvWzbC9A-phosphate structures. Benzylphosphonate, phosphate, the residues Cys9/Ala9 and Asp119 are shown as sticks and indicated.
The active site crevice of VvWzb
Like other LMWPTPs, the active site crevice of free VvWzb is composed of the P-loop (residues Cys9−Ser16), D-loop (residues Lys115−Gln123), and W-loop (residues Ile37−Lys47) (Figs. 2A and 4A). The P-loop, containing the catalytic motif 9CVGNICRS16, with Cys9 as the catalytic nucleophile, forms the bottom part of the crevice. The residues Asp119, Tyr121, and Arg122 of the D-loop are stacked together above the P-loop to form a wall of the crevice, and the W-loop forms the opposite wall. The W-loop of VvWzb, which is longer than any known LMWPTP by harboring a four-residue insert (40EKSR43), bulges out, with residues Ser42, Arg43, and Leu44 located at the tip region and residue Glu40 pointing toward the active site. Compared with the D-loop wall, which is relatively orthogonal to the P-loop bottom, the W-loop wall seems to be laid flat. In such a configuration, the active site crevice of free VvWzb is wide and shallow, being readily accessible for the substrate (Fig. S2). Due to the presence of Glu40, the W-loop wall region of the crevice is negatively charged. In the absence of ligand, the supposed phosphate-binding site is occupied by a chloride ion and a few water molecules; they interact with the P- and D-loop residues via extensive hydrogen bonding (Fig. 4A).
Figure 4.
Close-up of the active site regions.A, free VvWzb. B, VvWzb-benzylphosphonate complex. C, VvWzbC9A-phosphate complex. The P-, D-, and W-loops are colored in yellow, cyan, and magenta, respectively. Key residues and the ligands are represented in sticks; chloride ion and water molecules are represented by green and red spheres, respectively. The hydrogen bonds are shown as red dotted lines.
In VvWzb-benzylphosphonate complex, the substrate-mimicking benzylphosphonate is located at the bottom of the active site crevice. Its phosphonate group forms an extensive hydrogen-bonding network with the P-loop, including the main chain amide groups of the residues Val10, Gly11, Asn12, Ile13, Cys14, and Arg15, as well as the sulfhydryl group of Cys9 and the side-chain guanidine group of Arg15. The benzyl group of benzylphosphonate is flanked by residues Val10 of the P-loop and Tyr121 of the D-loop and further stabilized by Leu44 of the W-loop and Ile13 of the P-loop via hydrophobic interactions (Fig. 4B). Compared with the free structure, the W-loop undergoes a dramatic conformational rearrangement from an open to a closed conformation. Consequently, Glu40 is no longer oriented toward the active site cavity but turns outside. Instead, side chains of Ser42 and Leu44 turn to face the active site, forming the W-loop wall. In addition, side chains of Asp119 and Tyr121 of the D-loop also made small local conformational changes to interact with the ligand (Fig. 4, A and B). All these conformational changes significantly reconfigure the active site crevice, which is narrower and deeper in shape as well as more positively charged compared with that of free VvWzb (Fig. S2).
VvWzbC9A-phosphate shares a similar active site structure with the VvWzb-benzylphosphonate complex. Mutating Cys9 to an alanine residue that has a short and uncharged side chain allowed the phosphate ion to burry deeper in the active site than the phosphonate moiety of benzylphosphonate (Fig. 3C). As a result, the hydrogen bonds between the phosphate ion and the P-loop residues are generally shorter than those observed in VvWzb-benzylphosphonate, suggesting a stronger binding. Among these interactions, two hydrogen bonds contributed by the main-chain NH and the side-chain hydroxyl group of Ser16 are not observed in the VvWzb-benzylphosphonate complex. Overall, the structure of VvWzbC9A-phosphate mimics that of the phosphoryl-enzyme intermediate, judged by the position and orientation of the phosphate ion (28, 32). At the distance of about 3.5 Å to the phosphorous atom, we identified a water molecule that forms a hydrogen bond with Asp119 (Fig. 4C). This water molecule is assumed to be activated by Asp119 and functions as a nucleophile in the dephosphorylation reaction of the phosphoryl-enzyme intermediate. The phosphate ion does not interact directly with the D- and W-loop residues; however, the conformations of these loops are similar to those observed in VvWzb-benzylphosphonate complex, suggesting that the phosphate ion alone is sufficient to induce the conformational changes of the D- and W-loops. The electrostatically repelling between Glu40 and the phosphate ion is supposed to be an important driving force for the structural rearrangement of the W-loop. Overall, the shape and charge distribution of the active site crevice are similar to that in the VvWzb-benzylphosphonate complex.
Structural comparison with other LMWPTPs
As expected, a number of known LMWPTPs were identified by the Dali server to be structurally similar to VvWzb. Generally, VvWzb shares more similarity in structure and sequence with the EcWzb-prototyped group II LMWPTPs (rmsd of aligned Cα atoms of 0.8–0.9 Å2, sequence identity of 52–58%) than the group I LMWPTPs prototyped by mammalian LMWPTPs (rmsd of aligned Cα atoms of 1.4–1.9 Å2, sequence identity of 22–37%). In addition, arsenate reductases were also identified to be structurally similar to VvWzb (rmsd of aligned Cα atoms of about 2.1 Å2, sequence identity of about 23%), supporting the proposal that LMWPTP originated from prokaryotic arsenate reductase (20).
We chose two typical LMWPTPs, group II prototype EcWzb (PDB ID: 2WJA, sequence identity of 57% to VvWzb) and group I prototype BPTP (PDB ID: 1DG9, sequence identity of 29% to VvWzb) for comparison to understand the similarity and difference between VvWzb and other LMWPTPs (Fig. 5). All structures are in ligand-bound forms. Overall, structures of VvWzb, EcWzb, and BPTP could be well aligned for the regulatory secondary structures, with relatively large variations mainly occurring in the loop regions (Fig. 5A). We focused on the comparison of the active site crevices, which directly determine the substrate specificity and catalytic power. The P-loops of VvWzb, EcWzb, and BPTP contain the motifs “CVGNICRS”, “CTGNICRS,” and “CLGNICRS”, respectively. Despite the sequence variation at the second position of the catalytic motif, the P-loops of all structures are well superposed in space, in agreement with the conserved phosphate-binding function of this loop. Regarding the D-loop, VvWzb shares more similarity with EcWzb than with BPTP. VvWzb and EcWzb contain one tyrosine residue followed by an arginine residue in the D-loop, while BPTP contains two tyrosine residues (Tyr131 and Tyr132) (Fig. 5B). These two adjacent tyrosine residues are generally found in group I LMWPTPs, endowing their D-loops with a phosphorylation-mediated regulatory function (33). Phosphorylation on the D-loop has also been observed in group II LMWPTP (34) and could occur in VvWzb as well, due to the similar D-loop compositions. In group I LMWPTPs, the D-loop can undergo conformational changes upon ligand binding (35), but this is not observed in group II LMWPTPs. For VvWzb, there were only certain local conformational changes in the D-loop upon ligand binding. Remarkably, the most varied region of all three enzymes is located at the W-loop (Fig. 5B). The W-loop of EcWzb is the shortest among the three; a leucine (Leu44) is supposed to interact hydrophobically with the substrate. BPTP contains a tryptophan (Trp49) in the W-loop, whose side chain can interact hydrophobically with the phenyl ring of the substrate. In VvWzb, the four-residue insertion is partially overlapped with the side chain of Trp49 of BPTP. These inserted residues do not show direct interactions with the ligand due to a long distance between them. Instead, a leucine residue in VvWzb (Leu44) corresponding to EcWzb Leu44 may provide hydrophobic interaction with the phenyl ring of the ligand. The specific configuration of these loops makes the active site crevice of VvWzb different from those of previously studied LMWPTPs in shape and charge (Fig. S2). In shape, the active site crevices of group II LMWPTPs are relatively small and shallow, while those of group I LMWPTPs appear large and deep, showing a higher W-loop wall, which is attributed to their characteristic aromatic residue in the W-loop. The active site crevice of VvWzb in the ligand-free state is small and shallow but becomes larger and deeper in the ligand-bound state, resembling those of group I LMWPTPs. Regarding charge, the active site crevices of all LMWPTPs share a positively charged bottom, attributed to the conserved Arg residue of the P-loop. Group I LMWPTPs prefer relatively neutral walls for the active site crevices, while group II tends to have more positive ones. In comparison, the active site crevice of VvWzb is the most positively charged, largely due to the extra residue Lys41 in its W-loop wall. Assumingly, the distinct shapes and charge patterns of the active site crevices would exert profound effects on substrate recognition and catalysis for LMWPTPs.
Figure 5.
Structural comparison of VvWzb, EcWzb, and BPTP.A, superimposition of the overall structures. The P-, D-, and W-loops are annotated. B, close-up of the active site region. The ligands and key residues are shown as sticks in their respective colors.
Enzymatic characterization of VvWzb and its mutants
VvWzb exhibited clear phosphatase activity in the assay using para-nitrophenyl phosphate (pNPP) as substrate (Table 2, Fig. S3). Compared with EcWzb, VvWzb has a remarkably higher kcat and a comparable Km. Overall, the catalytic efficiency (kcat/Km) of VvWzb is approximately eightfolds of that of EcWzb. To understand the roles of individual residues in catalysis, we made several mutants and measured their activities. Based on structural analysis and previous knowledge of LMWPTPs, residues in the P- and D-loops are supposed to play primary roles in catalysis of VvWzb: Cys9 is a nucleophile; Asp119 serves as the general acid/base in the catalysis; Arg15 is crucial to interact with the phosphate group to stabilize the transition state. Mutating these individual residues of VvWzb to alanine (VvWzbC9A, VvWzbR15A, and VvWzbD119A) almost abolished the enzymatic activity, conforming their essential roles in catalysis.
Table 2.
Enzyme kinetics data
| Protein | kcat (s−1) | Km (mM) | kcat/Km (mM−1∗s−1) | Relative activity (%) |
|---|---|---|---|---|
| VvWzb | 25.10 ± 0.24 | 3.94 ± 0.12 | 6.37 | 100 |
| VvWzbE40-R43del | 6.00 ± 0.20 | 14.32 ± 1.07 | 0.42 | 6.58 |
| VvWzbE40-R43delinsW | 25.56 ± 0.23 | 7.90 ± 0.63 | 3.24 | 50.78 |
| VvWzbK41A | 19.68 ± 1.16 | 6.03 ± 1.01 | 3.26 | 51.08 |
| VvWzbK41E | 26.60 ± 0.64 | 7.03 ± 0.49 | 3.78 | 59.42 |
| VvWzbS42A | 25.94 ± 0.20 | 4.21 ± 0.22 | 6.16 | 96.71 |
| VvWzbS42E | 32.08 ± 1.19 | 6.74 ± 0.44 | 4.76 | 74.78 |
| VvWzbE40-R43delinsAAAA | 31.02 ± 0.86 | 8.47 ± 0.27 | 3.66 | 57.52 |
| EcWzb | 2.84 ± 0.10 | 3.48 ± 0.24 | 0.82 | 100 (12.87)a |
| EcWzbA39_L40insEKSR | 9.34 ± 0.10 | 2.53 ± 0.03 | 3.69 | 450 (57.93)a |
| EcWzbA39_L40insAAAA | 6.09 ± 0.09 | 2.05 ± 0.10 | 2.97 | 362 (46.63)a |
The values of kcat and Km are expressed as mean ± SEM of three independent experiments. Relative activity is defined as the catalytic efficiency (kcat/Km) divided by that of WT. The kinetics of VvWzbC9A, VvWzbR15A, and VvWzbD119A were not determined for their very low activity.
The values in the parenthesis indicate the relative activity to that of WT VvWzb.
Compared with other LMWPTPs, the W-loop of VvWzb is special by containing a unique “40EKSR43” insertion (Fig. 2A). To probe the function of this insertion, we first deleted the four residues to mimic the W-loop of group II LMWPTPs. In comparison with the WT, the deletion mutant VvWzb E40-R43del exhibited about fourfolds decrease for kcat, while the substrate-binding affinity was also significantly lowered judged by the increased Km. Altogether, the deletion mutant showed a significant decrease in the catalytic efficiency up to 15 folds (Table 2, Fig. S3). We also replaced these four residues with a tryptophan to mimic group I LMWPTPs. The tryptophan variant VvWzb E40-R43delinsW showed a similar kcat to that of WT, but the substrate-binding affinity was lower than WT judged by the twofold Km value. Overall, it showed a half of the catalytic efficiency of WT, which is much higher than the deletion mutant. These results indicate that the four-residue insertion “40EKSR43” is required for an optimal activity of VvWzb, and the enhancing effect is even higher than a single tryptophan residue. We were able to find similar four-residue insertion in the W-loops of many VvWzb homologs, showing that Lys41 and Ser42 are conserved in the new type of W-loop (Fig. 2A). These two residues face toward the active site, possibly affecting ligand binding (Fig. 4B). Therefore, we tested the contributions of Lys41 and Ser42 to catalysis by mutagenesis. The mutants VvWzbK41A, VvWzbK41E, and VvWzbS42E maintained about half enzymatic activity of WT, and VvWzbS42A even showed an activity of 97% of that of WT. Apparently, the activity is not dependent on the side chain types at these two positions. To further test the sequence-independency hypothesis, we replaced “40EKSR43” with four alanine residues. Again, the VvWzbE40-R43delinsAAAA mutant showed more than half enzymatic activity of WT, with a slightly higher kcat and a doubled value of Km. This result confirmed that the residue type is not critical for the activity enhancing effect of the insertion. Probably, a local structure derived from a simple four-residue skeleton is sufficient for the enhancing effect. Taken together, the four-residue insertion in the W-loop of VvWzb endowed the enzyme with a higher enzymatic activity than null or tryptophan residue at the same position of the W-loop. The enhancing effect is not determined by the sequence specificity of the insertion.
We wondered if this enhancing effect of the four-residue insertion can also be applied to other LMWPTPs. Therefore, we performed a gain-of-function experiment by inserting the four residues in the corresponding position of EcWzb. Both mutants EcWzbA39-L40insEKSR and EcWzbA39-L40insAAAA showed a significant increase (∼fivefolds/fourfolds) in catalytic efficiency (Table 2, Fig. S3). The enhancing effect was mainly reflected by the increase in kcat, which is about three or two times of that of the WT. For both mutants, the Km values are slightly lowered, indicating a better substrate-binding affinity. These results suggest that a four-residue insertion at the W-loop can be a general activity enhancing element for the LMWPTP fold.
All aforementioned results are based on the enzymatic assays using pNPP as the substrate. We wondered if these results can be verified when using a physiological substrate. We purified VvWzc453−726, the Y-cluster of which serves as the natural substrate of VvWzb. The recombinant VvWzc453–726 showed two bands that were stained by the anti-phosphotyrosine antibody, probably representing two phosphorylation states. After incubation with WT VvWzb and the mutants, we observed dephosphorylation of VvWzc453−726 to various extents. The WT dephosphorylated VvWzc453−726 in a short time period, but did not lead to a complete dephosphorylation. The mutants VvWzbK41A, VvWzbK41E, VvWzbS42A, and VvWzbE40-R43delinsAAAA showed 82% to 94% dephosphorylating activities of the WT, while the activity of VvWzb E40-R43del is poor, with 22% activity retained (Fig. 6). In general, the relative activities of these mutants showed the same trend as that observed in the pNPP assays. Interestingly, the mutant VvWzbS42E showed inconsistent results in the two assays. In the pNPP assay, this mutant showed a high enzymatic activity, similar to that of other point mutations (Table 2, Fig. S3). However, its activity (33% activity of WT) was much lower than other point mutants but comparable with that of the deletion mutant, when using VvWzc453−726 as substrate (Fig. 6). This phenomenon indicates that an unfavourable interaction between the W-loop of VvWzbS42E and VvWzc453−726 occurred, resulting in enzymatic activity loss.
Figure 6.
Dephosphorylation of VvWzc453−726by VvWzb and its mutants. The upper panel shows a representative western blot of VvWzc453−726 stained by anti-phosphotyrosine antibody after incubation with VvWzb and the mutants. The lower panel shows the relative enzymatic activity of these enzymes. The error bars stand for the standard deviation values (n = 3).
Discussion
Herein, we report the crystal structures of VvWzb in free and ligand-bound forms. VvWzb contains an unusual W-loop with a four-residue insertion, which is required for the optimal activity. This is the first report to identify and characterize such a novel W-loop in the LMWPTP family.
Remarkably, the unique insertion in the W-loop endows VvWzb with unprecedented structural and functional features in the LMWPTP family. The P- and D-loop regions of VvWzb resemble those of known LMWPTPs, but its W-loop is longer than any other known LMWPTPs for containing a unique four-reside insertion. The W-loop of VvWzb exhibited an extended conformation in ligand-free state but underwent dramatic conformational changes upon ligand binding, which reconfigured the shape and charges of the active site crevice. Conformational changes in the W-loop were reported in group I LMWPTPs before, but they were only small changes on the orientation of the tryptophan side chain (35). This is the first time to observe such a large conformational change of the W-loop in the LMWPTP family. Importantly, the unique four-residue insertion in the W-loop of VvWzb showed functional importance. The insertion not only was required for an optimal activity of VvWzb but also enhanced the activity of EcWzb once incorporated into the latter at the corresponding position. Roughly, the enhancing effect of the four-residue insertion is comparable with that of a tryptophan residue. The exact mechanism of the enhancement remains to be understood, but it is obviously different from that of an aromatic residue, which stabilizes the phenyl ring of the substrate to gain higher catalytic power (23). Surprisingly, substituting the insertion to a simple four-alanine patch is sufficient to maintain a high enzymatic activity. It appears that the space effect instead of the sequence specificity of the insertion makes the major contribution to activity enhancement. Interestingly, we also observed that the VvWzbS42E mutant showed a largely reduced enzymatic activity when using VvWzc453−726 as substrate, even though its activity was comparable with that of WT when using pNPP as substrate. In the complex structures, Ser42 points to the active site pocket. When substituting to Glu, the longer side chain may hinder the localization of the Y-cluster of VvWzc453−726, whereas this is less hazardous for the smaller substrate pNPP. Alternatively, the W-loop of VvWzbS42E interacts with VvWzc453−726 and thus is not able to take the correct conformation for catalysis. Either explanation inspires a hypothesis of regulation mechanism. It is known that glutamic acid residue is a mimic of phosphoserine. In fact, Ser42 is located at the tip region of the W-loop as shown in the ligand-free VvWzb structure and thus easily accessible by a kinase. It is plausible that Ser42 of VvWzb can be phosphorylated and thus regulate the enzymatic activity. The hypothesis is not unreasonable, considering that phosphorylation-mediated regulation has been reported for LMWPTPs (36). This might explain why the serine residue is conserved in this new type of W-loop (Fig. 2A).
Our study also raises a request to update the current classification of LMWPTP family. In the last decades, a number of LMWPTP structures have been determined and there are only two types of W-loop identified (23). The W-loop containing a characteristic aromatic residue has been identified in the majority of the LMWPTP structures, including BPTP (PDB ID: 1DG9), HCPTPA (PDB ID: 5PNT), HCPTPB (PDB ID: 1XWW), and VcLMWPTP1(PDB ID: 4LRQ) (25, 26, 32, 37). The other type of W-loop lacks this aromatic residue, found in structures such as EcWzb (PDB ID: 2WJA), EaAmsI (PDB ID: 4D74), and VcLMWPTP2 (PDB ID: 5Z3M) (29, 38, 39). The two types of W-loop employ distinct substrate recognition mechanisms (23). Interestingly, phylogenetic analysis has divided LMWPTPs into two groups, which is parallel to their W-loop types (23, 31). This supports the role of W-loop as an evolutional marker in classification of the LMWPTP family. Apparently, VvWzb employs a new type of W-loop and is outside of either group. Moreover, this type of W-loop is not limited to V. vulnificus, but spreads widely in the γ-proteobacteria class, including the families of Vibrionaceae, Enterobacteriaceae, and Pasteurellaceae. Further, we carried out a phylogenetic analysis that grouped the LMWPTPs into three clades, including the previously known two groups and the third one containing VvWzb and its homologs (Fig. 7). In agreement with previous observation, the phylogenetic grouping is obviously in parallel to the W-loop types. Taken the W-loop type and phylogenetic relationship together, we suggest to reclassify LMWPTPs into three groups: I to III, prototyped by mammalian LMWPTPs, EcWzb, and VvWzb, respectively. It is known that indels, referring to short insertions and deletions in the protein sequence, are a major force to drive protein evolution to gain new structural folds, new functionalities, and new regulations (40, 41, 42). W-loop diversity in LMWPTPs is an excellent example in this context. Based on previous results and our study, it is clear that indel variations in the W-loop endow LMWPTPs with specific structural, dynamic, and mechanical features. The coincidence between the W-loop types and phylogenetic relationship also demonstrates that indel occurring at the W-loop plays important roles in driving the evolution and diversity of LMWPTP family.
Figure 7.
Phylogenetic analysis of the LMWPTP family. LMWPTPs from prokaryotes and eukaryotes are shown in black and red words, respectively.
Characterization of the protein tyrosine phosphorylation system in prokaryotes is still at infancy in comparison with that in eukaryotes (43). LMWPTPs are important components in both prokaryotic and eukaryotic tyrosine phosphorylation systems. Here, we notice a difference in their LMWPTP diversities. Based on the phylogenetic tree, eukaryotes use only group I LMWPTPs (Fig. 7). This sole type of LMWPTPs can dephosphorylate an array of protein substrates in various cellular processes (1). In contrast, prokaryotes employ all three groups of LMWPTPs. It is not unusual that one species contains two groups of LMWPTPs, being a combination of any two groups. For example, V. vulnificus contains group I (protein ID: WP_130193014.1) and III (protein ID: WP_017420711.1) LMWPTPs. Even, some species contain all three groups, exemplified by E. coli (with protein IDs: WP_153671227.1, WP_052935621, and AYN88831.1) and Vibrio cholerae (with protein IDs: WP_001909008.1, WP_001880745.1, and WP_114808776.1). It is also interesting to find that a similar biochemical process in different species can employ different groups of LMWPTPs. For instance, the above-mentioned EcWzb (group II) and VvWzb (group III) are all related to polysaccharide synthesis (18, 44). Since W-loop plays an important role in substrate recognition and ligand regulation (25), using diverse LMWPTPs with all types of W-loops may endow prokaryotes with certain advantages in substrate spectrum and regulation to adapt to their large variety of cellular processes. It is known that most prokaryotes use BY-kinases, with no homologs in eukaryotes (45). Now, from both the aspects of kinase and phosphatase, it is clearer that prokaryotic tyrosine phosphorylation system is not analogous to that of eukaryotes, but has its own unique characteristics. The evolutional relationship between prokaryotic and eukaryotic tyrosine phosphorylation systems is an interesting question for future study.
Finally, our study also provides an opportunity to develop antivirulence agents against V. vulnificus. LMWPTP family members have been proposed in recent years as promising drug targets for human diseases, including cancer, diabetes, and infectious diseases, with many potential inhibitors developed (46, 47, 48). Obviously, inhibiting VvWzb would damage the CPS production of V. vulnificus and thus render the bacterium to the biocidal attack of the host immune system, making VvWzb an excellent antivirulence target. Our structural analysis of VvWzb in free and ligand-bound forms has described a clear profile of its ligand-binding pocket, facilitating inhibitor development through a structure-based approach. The chemical compounds developed for other LMWPTPs can be a good start to design VvWzb inhibitors. More importantly, the unique insertion in the W-loop endows VvWzb with an active site pocket distinct from that of the LMWPTPs of the eukaryotic hosts and most microbiota bacteria, giving a good opportunity to develop pathogen-specific inhibitors. To note, conformational changes of the W-loop of VvWzb may be induced by inhibitor binding, which should be taken into account during inhibitor developing process.
Experimental procedures
Gene cloning and protein production
The DNA sequence encoding VvWzb was amplified from the genomic DNA of V. vulnificus ATCC 27562 by standard PCR method using primers (forward, 5′-AGTCCATGGGCTTTAACAAAATCTTAGTCGTTTG-3′; reverse, 5′-CCGCTCGAGCTACAATTTTTTTGCCCAG-3′). The PCR product was inserted into the vector pETM11 (EMBL) using NcoI and XhoI sites. The product from this construct would be composed of an N-terminal 6×His tag, a tobacco etch virus (TEV) cleavage site, and the VvWzb coding sequence.
The sequence-verified gene construct was transformed into the E. coli C43 (DE3) strain. The strain was cultivated in Luria–Bertani (LB) broth medium containing 50 μg/ml kanamycin. When the OD600 value reached about 0.8, isopropyl-β-D-thiogalactopyranoside (IPTG) at a final concentration of 200 μM was added to induce the overexpression of the target protein. The induced cells were further cultured at 16 °C for 14 h with vigorous shaking. Subsequently, the cells were harvested by centrifugation at 6000g for 10 min. The cell pellets were resuspended in the binding buffer containing 50 mM Tris--HCl pH 8.0, 150 mM NaCl, then lysed by high-pressure cell disruptor. The lysate was centrifuged at 15,000g for 1 h at 4 °C, and the supernatant was loaded onto a nickel-chelating Sepharose affinity chromatography column (BBI). The purified protein was eluted with the buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 250 mM imidazole. Then the protein solution was changed to 50 mM TrisHCl pH 8.0, 150 mM NaCl using a PD-10 column (GE Healthcare) for TEV (with His-tag) digestion. The tag-uncleaved protein and TEV were removed by reloading the solution onto the nickel-chelating Sepharose affinity chromatography column. The flow-through containing untagged protein was collected, concentrated, and purified using gel filtration on a HiLoad 16/600 Superdex 75 column (GE Healthcare) equilibrated with the buffer containing 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT. The purified protein was concentrated to approximately 20 mg/ml as determined by the absorbance at 280 nm, then used immediately or freshly frozen at −80 °C for later use.
EcWzb gene was cloned from the E. coli strain K12 and incorporated into pETM11 using ClonExpressII One Step Cloning Kit (Vazyme). The mutant genes in this study were prepared by overlapping PCR and inserted into pETM11 vector using restriction-ligation method or ClonExpressII One Step Cloning Kit (Vazyme). The overexpression and purification procedures were similar to those of WT VvWzb.
To prepare the protein substrate for VvWzb, the DNA sequence encoding the C-terminal amino acid residues 453 to 726 of Wzc of V. vulnificus ATCC 27562 (VvWzc453−726) was amplified by primer (forward, 5′-TTTATTTTCAGGGCGCCATGAAAGCGGCACTTCACCGT-3′; reverse, 5′-TTGTCGACGGAGCTCTTACGCTTTATTACTCTCACCAT-3′) and inserted into pETM11 vector (EMBL) and expressed in E.coli BL21 (DE3) strain. The purification procedures were the same as those of VvWzb.
Crystallization and structure determination
Crystallization was conducted with the sitting-drop vapor-diffusion method at 20 °C. Free VvWzb crystals were grown in drops containing 1.5 μl of protein solution (14 mg/ml in the buffer 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT) and 1.5 μl of reservoir solution (100 mM HEPES pH7.5, 200 mM NaCl, 31% (w/v) PEG3350). The reservoir solution supplemented with 4% (w/v) PEG3350 was used as cryoprotectant solution. We also crystallized VvWzb and VvWzbC9A in the presence of benzylphosphonate. First, benzylphosphonic acid dissolved in 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT was titrated by NaOH to result in a 300 mM benzylphosphonate solution of pH 7.5. Then, VvWzb or VvWzbC9A solution was mixed with the benzylphosphonate solution and incubated at 4 °C for 1 h. Complex crystals were grown in drops containing 1.5 μl of protein solution (14 mg/ml protein in the buffer 10 mM HEPES, 30 mM benzylphophonate, 150 mM NaCl, 1 mM DTT, pH 7.5) and 1.5 μl of reservoir solution (100 mM HEPES pH 7.0, 25% (w/v) PEG3350). The reservoir solution supplemented with 10% glycerol and 30 mM benzylphophonate pH 7.5 was used as cryoprotectant solution. The crystals were shortly soaked in their respective cryoprotectant solutions, prior to flash-freezing in liquid nitrogen for data collection.
The diffraction data were collected at 100 K on the beamlines BL18U1 and BL19U1 of Shanghai Synchrotron Radiation Facility (SSRF) (49, 50). The diffraction data were processed by autoPROC (Global Phasing) calling the programs XDS and Aimless (51, 52, 53). The structure of free VvWzb was solved by molecular replacement using Phaser (54), with the structure of EcWzb (PDB ID: 2WMY) as search model. Refinement of the atomic coordinates, B-factors, and TLS parameters using autoBUSTER (55) and model building using Coot (56) were carried out alternately. The chloride ions in free VvWzb structure were identified on the basis of electron density, anomalous signal, and stereochemistry (57). The ligand-bound structures were solved by molecular replacement using the ligand-free structure as search model. The refinement protocol of the ligand-bound WT VvWzb is similar to that of the free form. For ligand-bound VvWzbC9A, which diffracted to atomic resolution, the atomic coordinates and anisotropic B-factors were refined using Phenix.refine (58). Ligands were modeled at late stage of refinement, and the geometry restraints of ligands were generated by the GRADE server (http://grade.globalphasing.org). All the crystallographic data are summarized in Table 1.
Structure similarity searching was performed on the Dali webserver (59). Sequence alignment was performed on the ESPript server (60). Protein intereaction interface was analyzed with the PISA program (61). The MolProbity server (62) and other programs in the CCP4 and Phenix packages were also used for structure analysis (63, 64). Pymol (Schrödinger) was used for structure superimposition, surface charge analysis, and structural graphics preparation.
Phosphatase activity assays
The phosphatase activities of VvWzb and mutants were measured by an assay using pNPP as substrate. VvWzb can dephosphorylate pNPP into p-nitrophenol, whose absorbance can be recorded at 405 nm. The determination of kinetic parameters was carried out in a 300 μl reaction system containing 10 mM HEPES pH 7.5, 150 mM NaCl supplemented with 0.45 to 57.6 mM pNPP and different amount of enzyme (100 nM for VvWzb and its mutants except 400 nM for VvWzb E40-R43del; 200 nM for EcWzb and its mutants). Absorbance at 405 nm was recorded continuously on a Cary 60 UV-Vis spectrophotometer (Agilent Technologies) with 10-mm path length cuvettes at 20 °C to obtain the progress curve, which was used to calculate the initial velocity. A standard curve of the product p-nitrophenol was drawn to convert absorbance values to p-nitrophenol concentrations. Kinetics parameters were estimated by nonlinear fitting of the initial velocity versus substrate concentration data to the Michaelis–Menten equation (v= Vmax[S]/(Km+[S])) using the Origin program.
The phosphatase activities of VvWzb and the mutants were also tested using recombinant VvWzc453−726 as substrate. In detail, 10 μM VvWzc453−726 with 3 μM VvWzb or its mutants was incubated in 10 μl reaction buffer (50 mM HEPES pH 7.5, 150 mM NaCl) at 4 °C for 0.5 h. Then the SDS-PAGE sample buffer was added to terminate the reactions. Samples were heated at 95 °C for 5 min, separated on 12% SDS-PAGE gels, and transferred onto PVDF membranes using a wet transferring protocol with constant current 200 mA. Membranes were firstly incubated with monoclonal anti-phosphotyrosine antibody (1:2000 diluted ab10321; Abcam), followed by incubation with goat anti-mouse IgG-HRP (1:5000 diluted CW0102S; CWBIO). Immunodetection was performed using the DAB kit (CW0125S; CWBIO). The intensity of the bands was quantified using the Image J software. The activity was evaluated by the intensity difference between samples and the control.
Phylogenetic analysis
The rootless protein phylogenetic tree was constructed by MEGA6 software using the neighbor-joining method. In total, 26 representative LMWPTP sequences including eukaryotic and prokaryotic ones were used for analysis (with NCBI numbers in the parentheses): BPTP Bos taurus (NP_776403.1), HCPTPA human (NP_004291.1), Stp1 S. pombe (NP_001342920.1), LMWPTP Mus (NP_001103709.1), LMWPTP1 V. cholerae (WP_001889901.1), PTP H. felis (OOS02738.1), MptpA Mycobacterium tuberculosis (WP_003411510.1), LMWPTP S. humiferus (WP_003975011.1), LMWPTP A. lwoffii (WP_004278810.1), PTP Erwinia amylovora (WP_004158327.1), LMWPTP R. solanacearum (WP_193029717.1), Wzb S. sonnei (EFW8105757.1), Wzb E. coli (NP_416565.1), Wzb S. enterica (WP_000482223.1), Wzb K. pneumoniae (AAD30006.1), Wzb Escherichia hormaechei (ESL87399.1), PTP C. sakazakii (KDP98850.1), Wzb V. vulnificus (WP_017420711.1), LMWPTP V. cholerae (WP_114808776.1), Wzb Vibrio parahaemolyticus (WP_005458338.1), Wzb Vibrio harveyi (WP_021018098.1), Wzb Vibrio crassostreae (WP_055320062.1), PTP A. sifiae (WP_061013219.1), PTP P. damselae (WP_065171812.1), LMWPTP E. coli (WP_122056837.1), and LMWPTP G. parasuis (WP_010785901.1). One thousand bootstrap replicates were used to test the inferred phylogeny relationship. The final clustering result was generated and displayed with radiation.
Data availability
The coordinates and diffraction data of the free VvWzb, VvWzb-benzylphosphonate, and VvWzbC9A-phosphate have been deposited in the PDB (www.rcsb.org) with accession numbers of 7DHD, 7DHE, and 7DHF, respectively. All remaining data are contained within the article and the supporting information file.
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
Acknowledgments
We thank Chongyang Wang and Dr Changshui Liu for technical support. We also thank the staff from the BL18U1 and BL19U1 beamlines at Shanghai Synchrotron Radiation Facility for assistance in data collection.
Author contributions
X. W. and Q. M. designed, performed and analyzed the experiments, and wrote the paper; Q. M. conceived and supervised the study; X. W. and Q. M. reviewed the results and approved the final version of the manuscript.
Funding and additional information
This work was supported by “Qingdao Innovation Leadership Program” (No. 18-1-2-12-zhc) and “Aoshan Talents Program” of the Pilot National Laboratory for Marine Science and Technology (No. 2015ASTP) to Q. M.
Edited by Joseph Jez
Footnotes
This article contains supporting information.
Supporting information
References
- 1.Hunter T. The genesis of tyrosine phosphorylation. Cold Spring Harb. Perspect. Biol. 2014;6 doi: 10.1101/cshperspect.a020644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Grangeasse C., Doublet P., Vaganay E., Vincent C., Deléage G., Duclos B., Cozzone A.J. Characterization of a bacterial gene encoding an autophosphorylating protein tyrosine kinase. Gene. 1997;204:259–265. doi: 10.1016/s0378-1119(97)00554-4. [DOI] [PubMed] [Google Scholar]
- 3.Kumagai T., Kihara H., Watanabe W., Noda M., Matoba Y., Sugiyama M. A novel tyrosine-phosphorylated protein inhibiting the growth of Streptomyces cells. Biochem. Biophys. Res. Commun. 2009;385:534–538. doi: 10.1016/j.bbrc.2009.05.091. [DOI] [PubMed] [Google Scholar]
- 4.Petrova O.E., Sauer K. Dispersion by Pseudomonas aeruginosa requires an unusual posttranslational modification of BdlA. Proc. Natl. Acad. Sci. U. S. A. 2012;109:16690–16695. doi: 10.1073/pnas.1207832109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schwechheimer C., Hebert K., Tripathi S., Singh P.K., Floyd K.A., Brown E.R., Porcella M.E., Osorio J., Kiblen J.T.M., Pagliai F.A., Drescher K., Rubin S.M., Yildiz F.H. A tyrosine phosphoregulatory system controls exopolysaccharide biosynthesis and biofilm formation in Vibrio cholerae. PLoS Pathog. 2020;16 doi: 10.1371/journal.ppat.1008745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ilan O., Bloch Y., Frankel G., Ullrich H., Geider K., Rosenshine I. Protein tyrosine kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide. EMBO J. 1999;18:3241–3248. doi: 10.1093/emboj/18.12.3241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hansen A.M., Chaerkady R., Sharma J., Diaz-Mejia J.J., Tyagi N., Renuse S., Jacob H.K.C., Pinto S.M., Sahasrabuddhe N.A., Kim M.S., Delanghe B., Srinivasan N., Emili A., Kaper J.B., Pandey A. The Escherichia coli phosphotyrosine proteome relates to core pathways and virulence. PLoS Pathog. 2013;9 doi: 10.1371/journal.ppat.1003403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Esser D., Pham T.K., Reimann J., Albers S.V., Siebers B., Wright P.C. Change of carbon source causes dramatic effects in the phosphoproteome of the archaeon Sulfolobus solfataricus. J. Proteome Res. 2012;11:4823–4833. doi: 10.1021/pr300190k. [DOI] [PubMed] [Google Scholar]
- 9.Grangeasse C., Cozzone A.J., Deutscher J., Mijakovic I. Tyrosine phosphorylation: An emerging regulatory device of bacterial physiology. Trends Biochem. Sci. 2007;32:86–94. doi: 10.1016/j.tibs.2006.12.004. [DOI] [PubMed] [Google Scholar]
- 10.Whitmore S.E., Lamont R.J. Tyrosine phosphorylation and bacterial virulence. Int. J. Oral Sci. 2012;4:1–6. doi: 10.1038/ijos.2012.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Getz L.J., Runte C.S., Rainey J.K., Thomas N.A. Tyrosine phosphorylation as a widespread regulatory mechanism in prokaryotes. J. Bacteriol. 2019;201:e00205–e00219. doi: 10.1128/JB.00205-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Baker-Austin C., Oliver J.D. Vibrio vulnificus: New insights into a deadly opportunistic pathogen. Environ. Microbiol. 2018;20:423–430. doi: 10.1111/1462-2920.13955. [DOI] [PubMed] [Google Scholar]
- 13.Fouz B., Larsen J.L., Amaro C. Vibrio vulnificus serovar A: An emerging pathogen in European anguilliculture. J. Fish Dis. 2006;29:285–291. doi: 10.1111/j.1365-2761.2006.00719.x. [DOI] [PubMed] [Google Scholar]
- 14.Pettis G.S., Mukerji A.S. Structure, function, and regulation of the essential virulence factor capsular polysaccharide of Vibrio vulnificus. Int. J. Mol. Sci. 2020;21:3259. doi: 10.3390/ijms21093259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wright A.C., Powell J.L., Kaper J.B., Morris J.G., Jr. Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect. Immun. 2001;69:6893–6901. doi: 10.1128/IAI.69.11.6893-6901.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sachdeva S., Palur R.V., Sudhakar K.U., Rathinavelan T. E. coli group 1 capsular polysaccharide exportation nanomachinary as a plausible antivirulence target in the perspective of emerging antimicrobial resistance. Front. Microbiol. 2017;8:70. doi: 10.3389/fmicb.2017.00070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 2006;75:39–68. doi: 10.1146/annurev.biochem.75.103004.142545. [DOI] [PubMed] [Google Scholar]
- 18.Chatzidaki-Livanis M., Jones M.K., Wright A.C. Genetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operon. J. Bacteriol. 2006;188:1987–1998. doi: 10.1128/JB.188.5.1987-1998.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Phippen B.L., Oliver J.D. Role of anaerobiosis in capsule production and biofilm formation in Vibrio vulnificus. Infect. Immun. 2015;83:551–559. doi: 10.1128/IAI.02559-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Caselli A., Paoli P., Santi A., Mugnaioni C., Toti A., Camici G., Cirri P. Low molecular weight protein tyrosine phosphatase: Multifaceted functions of an evolutionarily conserved enzyme. Biochim. Biophys. Acta. 2016;1864:1339–1355. doi: 10.1016/j.bbapap.2016.07.001. [DOI] [PubMed] [Google Scholar]
- 21.Su X.D., Taddeit N., Stefanl M., Ramponlt G., Nordlund P. The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature. 1994;370:575–578. doi: 10.1038/370575a0. [DOI] [PubMed] [Google Scholar]
- 22.Zhang M., Van-Etten R.L., Stauffacher C.V. Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-Å resolution. Biochemistry. 1994;33:11097–11105. doi: 10.1021/bi00203a006. [DOI] [PubMed] [Google Scholar]
- 23.Lescop E., Hu Y., Xu H., Hu W., Chen J., Xia B., Jin C. The solution structure of Escherichia coli Wzb reveals a novel substrate recognition mechanism of prokaryotic low molecular weight protein-tyrosine phosphatases. J. Biol. Chem. 2006;281:19570–19577. doi: 10.1074/jbc.M601263200. [DOI] [PubMed] [Google Scholar]
- 24.Madhurantakam C., Rajakumara E., Mazumdar P.A., Saha B., Mitra D., Wiker H.G., Sankaranarayanan R., Das A.K. Crystal structure of low-molecular-weight protein tyrosine phosphatase from Mycobacterium tuberculosis at 1.9-Å resolution. J. Bacteriol. 2005;187:2175–2181. doi: 10.1128/JB.187.6.2175-2181.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhang M., Stauffacher C.V., Lin D., Van-Etten R.L. Crystal structure of a human low molecular weight phosphotyrosyl phosphatase. J. Biol. Chem. 1998;273:21714–21720. doi: 10.1074/jbc.273.34.21714. [DOI] [PubMed] [Google Scholar]
- 26.Zabell A.P., Schroff A.D., Jr., Bain B.E., Van Etten R.L., Wiest O., Stauffacher C.V. Crystal structure of the human B-form low molecular weight phosphotyrosyl phosphatase at 1.6-Å resolution. J. Biol. Chem. 2006;281:6520–6527. doi: 10.1074/jbc.M506285200. [DOI] [PubMed] [Google Scholar]
- 27.Ku B., Keum C.W., Lee H.S., Yun H.Y., Shin H.C., Kim B.Y., Kim S.J. Crystal structure of SP-PTP, a low molecular weight protein tyrosine phosphatase from Streptococcus pyogenes. Biochem. Biophys. Res. Commun. 2016;478:1217–1222. doi: 10.1016/j.bbrc.2016.08.097. [DOI] [PubMed] [Google Scholar]
- 28.Wang S., Tabernero L., Zhang M., Harms E., Van Etten R.L., Stauffacher C.V. Crystal structures of a low-molecular weight protein tyrosine phosphatase from Saccharomyces cerevisiae and its complex with the substrate p-nitrophenyl phosphate. Biochemistry. 2000;39:1903–1914. doi: 10.1021/bi991348d. [DOI] [PubMed] [Google Scholar]
- 29.Chatterjee S., Nath S., Ghosh B., Sen U. Vibrio cholerae LMWPTP-2 display unique surface charge and grooves around the active site: Indicative of distinctive substrate specificity and scope to design specific inhibitor. Biochim. Biophys. Acta. 2019;1867:114–124. doi: 10.1016/j.bbapap.2018.11.003. [DOI] [PubMed] [Google Scholar]
- 30.Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P., Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S., Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y., Alvarado J. Structural genomics of protein phosphatases. J. Struct. Funct. Genomics. 2007;8:121–140. doi: 10.1007/s10969-007-9036-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sánchez-Rodríguez R., González G.M., Becerril-García M.A., Treviño-Rangel R.J., Marcos-Vilchis A., Gonzalez-Pedrajo B., Valvano M.A., Andrade A. The BPtpA protein from Burkholderia cenocepacia belongs to a new subclass of low molecular weight protein tyrosine phosphatases. Arch. Biochem. Biophys. 2020;681:108277. doi: 10.1016/j.abb.2020.108277. [DOI] [PubMed] [Google Scholar]
- 32.Zhang M., Zhou M., Van-Etten R.L., Stauffacher C.V. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. Biochemistry. 1997;36:15–23. doi: 10.1021/bi961804n. [DOI] [PubMed] [Google Scholar]
- 33.Raugei G., Ramponi G., Chiarugi P. Low molecular weight protein tyrosine phosphatases: Small, but smart. Cell. Mol. Life Sci. 2002;59:941–949. doi: 10.1007/s00018-002-8481-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Nadler C., Koby S., Peleg A., Johnson A.C., Suddala K.C., Sathiyamoorthy K., Smith B.E., Saper M.A., Rosenshine I. Cycling of Etk and Etp phosphorylation states is involved in formation of group 4 capsule by Escherichia coli. PLoS One. 2012;7 doi: 10.1371/journal.pone.0037984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Stehle T., Sreeramulu S., Löhr F., Richter C., Saxena K., Jonker H.R.A., Schwalbe H. The apo-structure of the low molecular weight protein-tyrosine phosphatase A (MptpA) from Mycobacterium tuberculosis allows for better target-specific drug development. J. Biol. Chem. 2012;287:34569–34582. doi: 10.1074/jbc.M112.399261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tailor P., Gilman J., Williams S., Couture C., Mustelin T. Regulation of the low molecular weight phosphotyrosine phosphatase by phosphorylation at tyrosines 131 and 132. J. Biol. Chem. 1997;272:5371–5374. doi: 10.1074/jbc.272.9.5371. [DOI] [PubMed] [Google Scholar]
- 37.Nath S., Banerjee R., Sen U. Atomic resolution crystal structure of VcLMWPTP-1 from Vibrio cholerae O395: Insights into a novel mode of dimerization in the low molecular weight protein tyrosine phosphatase family. Biochem. Biophys. Res. Commun. 2014;450:390–395. doi: 10.1016/j.bbrc.2014.05.129. [DOI] [PubMed] [Google Scholar]
- 38.Hagelueken G., Huang H., Mainprize I.L., Whitfield C., Naismith J.H. Crystal structures of Wzb of Escherichia coli and CpsB of Streptococcus pneumoniae, representatives of two families of tyrosine phosphatases that regulate capsule assembly. J. Mol. Biol. 2009;392:678–688. doi: 10.1016/j.jmb.2009.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Salomone-Stagni M., Musiani F., Benini S. Characterization and 1.57-Å resolution structure of the key fire blight phosphatase AmsI from Erwinia amylovora. Acta Crystallogr. F Struct. Biol. Commun. 2016;72:903–910. doi: 10.1107/S2053230X16018781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Studer R.A., Dessailly B.H., Orengo C.A. Residue mutations and their impact on protein structure and function: Detecting beneficial and pathogenic changes. Biochem. J. 2013;449:581–594. doi: 10.1042/BJ20121221. [DOI] [PubMed] [Google Scholar]
- 41.Kim R.G., Guo J.T. Systematic analysis of short internal indels and their impact on protein folding. BMC Struct. Biol. 2010;10:24. doi: 10.1186/1472-6807-10-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zang K., Li F., Ma Q. The dUTPase of white spot syndrome virus assembles its active sites in a noncanonical manner. J. Biol. Chem. 2018;293:1088–1099. doi: 10.1074/jbc.M117.815266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Bechet E., Guiral S., Torres S., Mijakovic I., Cozzone A.J., Grangeasse C. Tyrosine-kinases in bacteria: From a matter of controversy to the status of key regulatory enzymes. Amino Acids. 2009;37:499–507. doi: 10.1007/s00726-009-0237-8. [DOI] [PubMed] [Google Scholar]
- 44.Stevenson G., Andrianopoulos K., Hobbs M., Reeves P.R. Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J. Bacteriol. 1996;178:4885–4893. doi: 10.1128/jb.178.16.4885-4893.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Chao J.D., Wong D., Av-Gay Y. Microbial protein-tyrosine kinases. J. Biol. Chem. 2014;289:9463–9472. doi: 10.1074/jbc.R113.520015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lori G., Paoli P., Caselli A., Cirri P., Marzocchini R., Mangoni M., Talamonti C., Livi L., Raugei G. Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. Cancer Med. 2018;7:1933–1943. doi: 10.1002/cam4.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Stanford S.M., Aleshin A.E., Zhang V., Ardecky R.J., Hedrick M.P., Zou J., Ganji S.R., Bliss M.R., Yamamoto F., Bobkov A.A., Kiselar J., Liu Y., Cadwell G.W., Khare S., Yu J. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat. Chem. Biol. 2017;13:624–632. doi: 10.1038/nchembio.2344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fanzani L., Porta1 F., Meneghetti F., Villa S., Gelain A., Lucarelli A.P., Parisini E. Mycobacterium tuberculosis low molecular weight phosphatases (MPtpA and MPtpB): From biological insight to inhibitors. Curr. Med. Chem. 2015;22:3110–3132. doi: 10.2174/0929867322666150812150036. [DOI] [PubMed] [Google Scholar]
- 49.Wang Z., Pan Q., Yang L., Zhou H., Xu C., Yu F., Wang Q., Huang S., He J. Automatic crystal centring procedure at the SSRF macromolecular crystallography beamline. J. Synchrotron Radiat. 2016;23:1323–1332. doi: 10.1107/S160057751601451X. [DOI] [PubMed] [Google Scholar]
- 50.Zhang W.Z., Tang J.C., Wang S.S., Wang Z.J., Qin W.M., He J.H. The protein complex crystallography beamline (BL19U1) at the Shanghai Synchrotron Radiation Facility. Nucl. Sci. Tech. 2019;30:170. [Google Scholar]
- 51.Vonrhein C., Flensburg C., Keller P., Sharff A., Smart O., Paciorek W., Womack T., Bricogne G. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 2011;67:293–302. doi: 10.1107/S0907444911007773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kabsch W. XDS. Acta Crystallogr. D Biol. Crystallogr. 2010;66:125–132. doi: 10.1107/S0907444909047337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Evans P.R., Murshudov G.N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 2013;69:1204–1214. doi: 10.1107/S0907444913000061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Smart O.S., Womack T.O., Flensburg C., Keller P., Paciorek W., Sharff A., Vonrhein C., Bricogne G. Exploiting structure similarity in refinement: Automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D Biol. Crystallogr. 2012;68:368–380. doi: 10.1107/S0907444911056058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Emsley P., Cowtan K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 57.Wan Y., Liu C., Ma Q. Structural analysis of a Vibrio phospholipase reveals an unusual Ser–His–chloride catalytic triad. J. Biol. Chem. 2019;294:11391–11401. doi: 10.1074/jbc.RA119.008280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Afonine P.V., Grosse-Kunstleve R.W., Echols N., Headd J.J., Moriarty N.W., Mustyakimov M., Terwilliger T.C., Urzhumtsev A., Zwart P.H., Adams P.D. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 2012;68:352–367. doi: 10.1107/S0907444912001308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Holm L., Rosenstrom P. Dali server: Conservation mapping in 3D. Nucleic Acids Res. 2010;38:W545–W549. doi: 10.1093/nar/gkq366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Robert X., Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42:W320–W324. doi: 10.1093/nar/gku316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Krissinel E., Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022. [DOI] [PubMed] [Google Scholar]
- 62.Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., Murray L.W., Arendall W.B., 3rd, Snoeyink J., Richardson J.S., Richardson D.C. MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007;35:W375–W383. doi: 10.1093/nar/gkm216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G.W., McCoy A., McNicholas S.J., Murshudov G.N., Pannu N.S., Potterton E.A., Powell H.R. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 2011;67:235–242. doi: 10.1107/S0907444910045749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W., McCoy A.J., Moriarty N.W., Oeffner R., Read R.J., Richardson D.C. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The coordinates and diffraction data of the free VvWzb, VvWzb-benzylphosphonate, and VvWzbC9A-phosphate have been deposited in the PDB (www.rcsb.org) with accession numbers of 7DHD, 7DHE, and 7DHF, respectively. All remaining data are contained within the article and the supporting information file.







